Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 5 June 2024.Powered by Capital Market - Live News

Bharat Parenterals announced that the Board of Directors of the Company at its meeting held on 22 May 2024, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net loss of Bharat Parenterals reported to Rs 0.30 crore in the quarter ended March 2024 as against net profit of Rs 2.49 crore during the previous quarter ended March 2023. Sales rose 33.06% to Rs 67.82 crore in the quarter ended March 2024 as against Rs 50.97 crore during the previous quarter ended March 2023.For the full year,net profit declined 11.68% to Rs 14.52 crore in the year ended March 2024 as against Rs 16.44 crore during the previous year ended March 2023. Sales rose 18.07% to Rs 257.36 crore in the year ended March 2024 as against Rs 217.98 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales67.8250.97 33 257.36217.98 18 OPM %1.4712.20 -8.699.12 - PBDT2.515.73 -56 27.7429.43 -6 PBT-1.364.29 PL 18.7223.55 -21 NP-0.302.49 PL 14.5216.44 -12 Powered by Capital Market - Live News

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 22 May 2024Powered by Capital Market - Live News

Bharat Parenterals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 21 May 2024 .Powered by Capital Market - Live News